Appropriate treatment in non‐pregnant people with inhibitors of the renin–angiotensin–aldosterone system (e.g., angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers) can substantially slow the progression of kidney disease and delay kidney failure by many years (Alshahrani, 2023). Here, ACE is linked to kidney failure.